SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000093751-23-000685
Filing Date
2023-10-10
Accepted
2023-10-10 11:27:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 Emergent_BioSolutions_Inc.txt SC 13G/A 6577
  Complete submission text file 0000093751-23-000685.txt   8432
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Subject) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82602 | Film No.: 231316669
SIC: 2834 Pharmaceutical Preparations